Which has higher valuation and earnings, MMED or SOLV?

Solventum has higher revenue and earnings than MiniMed Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MiniMed Group $2.99B 1.34 N/A N/A N/A Solventum $8.33B 1.69 $1.56B $8.16 9.93

Does the media prefer MMED or SOLV?

In the previous week, MiniMed Group had 4 more articles in the media than Solventum. MarketBeat recorded 10 mentions for MiniMed Group and 6 mentions for Solventum. Solventum's average media sentiment score of -0.04 beat MiniMed Group's score of -0.21 indicating that Solventum is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Solventum 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has stronger earnings & valuation, MMED or SNN?

Smith & Nephew SNATS has higher revenue and earnings than MiniMed Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MiniMed Group $2.99B 1.34 N/A N/A N/A Smith & Nephew SNATS $6.16B 2.12 $625M N/A N/A

Is MMED or SNN more profitable?

Company Net Margins Return on Equity Return on Assets MiniMed Group N/A N/A N/A Smith & Nephew SNATS N/A N/A N/A

Does the media prefer MMED or SNN?

In the previous week, MiniMed Group had 8 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 10 mentions for MiniMed Group and 2 mentions for Smith & Nephew SNATS. MiniMed Group's average media sentiment score of -0.21 beat Smith & Nephew SNATS's score of -1.00 indicating that MiniMed Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Smith & Nephew SNATS 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Which has better earnings & valuation, PEN or MMED?

Penumbra has higher earnings, but lower revenue than MiniMed Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Penumbra $1.40B 8.98 $177.69M $4.34 73.85 MiniMed Group $2.99B 1.34 N/A N/A N/A

Does the media prefer PEN or MMED?

In the previous week, MiniMed Group had 8 more articles in the media than Penumbra. MarketBeat recorded 10 mentions for MiniMed Group and 2 mentions for Penumbra. Penumbra's average media sentiment score of 0.73 beat MiniMed Group's score of -0.21 indicating that Penumbra is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, MMED or GKOS?

MiniMed Group has higher revenue and earnings than Glaukos. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MiniMed Group $2.99B 1.34 N/A N/A N/A Glaukos $507.44M 14.44 -$187.69M -$3.28 N/A

Does the media refer more to MMED or GKOS?

In the previous week, MiniMed Group had 7 more articles in the media than Glaukos. MarketBeat recorded 10 mentions for MiniMed Group and 3 mentions for Glaukos. Glaukos' average media sentiment score of 0.37 beat MiniMed Group's score of -0.21 indicating that Glaukos is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Glaukos 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer STVN or MMED?

MiniMed Group has a consensus price target of $21.33, indicating a potential upside of 49.92%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts clearly believe MiniMed Group is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.67 MiniMed Group 1 Sell rating(s) 2 Hold rating(s) 12 Buy rating(s) 0 Strong Buy rating(s) 2.73

Which has stronger earnings and valuation, STVN or MMED?

Stevanato Group has higher earnings, but lower revenue than MiniMed Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Stevanato Group €1.34B 4.19 €158.21M €0.59 31.49 MiniMed Group $2.99B 1.34 N/A N/A N/A

Does the media refer more to STVN or MMED?

In the previous week, MiniMed Group had 5 more articles in the media than Stevanato Group. MarketBeat recorded 10 mentions for MiniMed Group and 5 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 0.57 beat MiniMed Group's score of -0.21 indicating that Stevanato Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MiniMed Group 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

MiniMed Group (MMED) Competitors

$14.23 +0.17 (+1.21%)

Closing price 04:00 PM Eastern

Extended Trading

$14.13 -0.10 (-0.70%)

As of 07:26 PM Eastern

Compare

MMED vs. SOLV, SNN, PEN, GKOS, and STVN

Should you buy MiniMed Group stock or one of its competitors? MarketBeat compares MiniMed Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with MiniMed Group include Solventum (SOLV), Smith & Nephew SNATS (SNN), Penumbra (PEN), Glaukos (GKOS), and Stevanato Group (STVN). These companies are all part of the "medical equipment" industry.

How does MiniMed Group compare to Solventum?

MiniMed Group (NASDAQ:MMED) and Solventum (NYSE:SOLV) are both medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

Solventum has a net margin of 17.33% compared to MiniMed Group's net margin of 0.00%. Solventum's return on equity of 23.51% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
Solventum	17.33%	23.51%	7.63%

MiniMed Group presently has a consensus price target of $21.33, indicating a potential upside of 49.92%. Solventum has a consensus price target of $84.25, indicating a potential upside of 3.93%. Given MiniMed Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe MiniMed Group is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73
Solventum	1 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, MiniMed Group had 4 more articles in the media than Solventum. MarketBeat recorded 10 mentions for MiniMed Group and 6 mentions for Solventum. Solventum's average media sentiment score of -0.04 beat MiniMed Group's score of -0.21 indicating that Solventum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Solventum	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

19.7% of MiniMed Group shares are held by institutional investors. 2.2% of MiniMed Group shares are held by company insiders. Comparatively, 0.2% of Solventum shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Solventum has higher revenue and earnings than MiniMed Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$2.99B	1.34	N/A	N/A	N/A
Solventum	$8.33B	1.69	$1.56B	$8.16	9.93

Summary

MiniMed Group and Solventum tied by winning 6 of the 12 factors compared between the two stocks.

How does MiniMed Group compare to Smith & Nephew SNATS?

MiniMed Group (NASDAQ:MMED) and Smith & Nephew SNATS (NYSE:SNN) are both medical equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

In the previous week, MiniMed Group had 8 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 10 mentions for MiniMed Group and 2 mentions for Smith & Nephew SNATS. MiniMed Group's average media sentiment score of -0.21 beat Smith & Nephew SNATS's score of -1.00 indicating that MiniMed Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Smith & Nephew SNATS	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

MiniMed Group currently has a consensus target price of $21.33, indicating a potential upside of 49.92%. Smith & Nephew SNATS has a consensus target price of $30.93, indicating a potential upside of 0.98%. Given MiniMed Group's stronger consensus rating and higher possible upside, research analysts plainly believe MiniMed Group is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73
Smith & Nephew SNATS	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
Smith & Nephew SNATS	N/A	N/A	N/A

Smith & Nephew SNATS has higher revenue and earnings than MiniMed Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$2.99B	1.34	N/A	N/A	N/A
Smith & Nephew SNATS	$6.16B	2.12	$625M	N/A	N/A

19.7% of MiniMed Group shares are held by institutional investors. Comparatively, 25.6% of Smith & Nephew SNATS shares are held by institutional investors. 2.2% of MiniMed Group shares are held by insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

MiniMed Group beats Smith & Nephew SNATS on 6 of the 9 factors compared between the two stocks.

How does MiniMed Group compare to Penumbra?

Penumbra (NYSE:PEN) and MiniMed Group (NASDAQ:MMED) are both medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

Penumbra currently has a consensus price target of $361.33, indicating a potential upside of 12.74%. MiniMed Group has a consensus price target of $21.33, indicating a potential upside of 49.92%. Given MiniMed Group's stronger consensus rating and higher probable upside, analysts clearly believe MiniMed Group is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	0 Sell rating(s)	14 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.18
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73

In the previous week, MiniMed Group had 8 more articles in the media than Penumbra. MarketBeat recorded 10 mentions for MiniMed Group and 2 mentions for Penumbra. Penumbra's average media sentiment score of 0.73 beat MiniMed Group's score of -0.21 indicating that Penumbra is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

88.9% of Penumbra shares are owned by institutional investors. Comparatively, 19.7% of MiniMed Group shares are owned by institutional investors. 2.9% of Penumbra shares are owned by insiders. Comparatively, 2.2% of MiniMed Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Penumbra has higher earnings, but lower revenue than MiniMed Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.40B	8.98	$177.69M	$4.34	73.85
MiniMed Group	$2.99B	1.34	N/A	N/A	N/A

Penumbra has a net margin of 11.76% compared to MiniMed Group's net margin of 0.00%. Penumbra's return on equity of 10.87% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	11.76%	10.87%	8.45%
MiniMed Group	N/A	N/A	N/A

Summary

Penumbra beats MiniMed Group on 7 of the 12 factors compared between the two stocks.

How does MiniMed Group compare to Glaukos?

MiniMed Group (NASDAQ:MMED) and Glaukos (NYSE:GKOS) are both mid-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

19.7% of MiniMed Group shares are held by institutional investors. Comparatively, 99.0% of Glaukos shares are held by institutional investors. 2.2% of MiniMed Group shares are held by company insiders. Comparatively, 5.9% of Glaukos shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

MiniMed Group has higher revenue and earnings than Glaukos.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MiniMed Group	$2.99B	1.34	N/A	N/A	N/A
Glaukos	$507.44M	14.44	-$187.69M	-$3.28	N/A

MiniMed Group currently has a consensus target price of $21.33, indicating a potential upside of 49.92%. Glaukos has a consensus target price of $146.17, indicating a potential upside of 17.13%. Given MiniMed Group's higher probable upside, analysts plainly believe MiniMed Group is more favorable than Glaukos.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73
Glaukos	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.79

MiniMed Group has a net margin of 0.00% compared to Glaukos' net margin of -34.34%. MiniMed Group's return on equity of 0.00% beat Glaukos' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MiniMed Group	N/A	N/A	N/A
Glaukos	-34.34%	-6.92%	-5.25%

In the previous week, MiniMed Group had 7 more articles in the media than Glaukos. MarketBeat recorded 10 mentions for MiniMed Group and 3 mentions for Glaukos. Glaukos' average media sentiment score of 0.37 beat MiniMed Group's score of -0.21 indicating that Glaukos is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Glaukos	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

MiniMed Group beats Glaukos on 6 of the 11 factors compared between the two stocks.

How does MiniMed Group compare to Stevanato Group?

Stevanato Group (NYSE:STVN) and MiniMed Group (NASDAQ:MMED) are both mid-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, media sentiment and valuation.

Stevanato Group has a net margin of 11.76% compared to MiniMed Group's net margin of 0.00%. Stevanato Group's return on equity of 10.27% beat MiniMed Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.76%	10.27%	6.08%
MiniMed Group	N/A	N/A	N/A

19.7% of MiniMed Group shares are owned by institutional investors. 0.7% of Stevanato Group shares are owned by insiders. Comparatively, 2.2% of MiniMed Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, MiniMed Group had 5 more articles in the media than Stevanato Group. MarketBeat recorded 10 mentions for MiniMed Group and 5 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 0.57 beat MiniMed Group's score of -0.21 indicating that Stevanato Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MiniMed Group	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Stevanato Group has higher earnings, but lower revenue than MiniMed Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	€1.34B	4.19	€158.21M	€0.59	31.49
MiniMed Group	$2.99B	1.34	N/A	N/A	N/A

MiniMed Group has a consensus price target of $21.33, indicating a potential upside of 49.92%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts clearly believe MiniMed Group is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
MiniMed Group	1 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.73

Summary

MiniMed Group beats Stevanato Group on 7 of the 13 factors compared between the two stocks.

Get MiniMed Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MMED and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MMED vs. The Competition

Export

Metric	MiniMed Group	Surgical, Medical, And Dental Instruments And Supplies Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$4.00B	$2.57B	$4.24B	$11.97B
Dividend Yield	N/A	N/A	7.93%	5.32%
P/E Ratio	N/A	2.20	21.75	23.66
Price / Sales	1.34	452.68	213.09	86.29
Price / Cash	N/A	7.78	53.68	55.53
Price / Book	N/A	5.79	27.92	6.39
Net Income	N/A	-$69.38M	$109.80M	$337.36M
7 Day Performance	18.19%	-4.89%	-3.42%	-3.07%
1 Month Performance	21.83%	-2.48%	1.21%	0.37%
1 Year Performance	N/A	40.13%	12.95%	27.87%

MiniMed Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MMED MiniMed Group	3.405 of 5 stars	$14.23 +1.2%	$21.33 +49.9%	N/A	$4.00B	$2.99B	N/A	8,000	Earnings Report Analyst Forecast Options Volume
SOLV Solventum	2.1809 of 5 stars	$75.13 -1.1%	$84.25 +12.1%	+9.7%	$12.98B	$8.33B	9.21	20,000	High Trading Volume
SNN Smith & Nephew SNATS	1.8312 of 5 stars	$29.72 -0.2%	$30.93 +4.1%	+5.5%	$12.68B	$6.16B	N/A	16,988	Negative News Analyst Downgrade
PEN Penumbra	2.074 of 5 stars	$318.46 -0.2%	$361.33 +13.5%	+25.8%	$12.52B	$1.40B	73.38	4,700	News Coverage Positive News
GKOS Glaukos	2.3793 of 5 stars	$103.08 -3.2%	$146.17 +41.8%	+33.8%	$6.07B	$507.44M	N/A	1,094

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MMED) was last updated on 6/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MiniMed Group (MMED) Competitors

MMED vs. SOLV, SNN, PEN, GKOS, and STVN

How does MiniMed Group compare to Solventum?

Summary

How does MiniMed Group compare to Smith & Nephew SNATS?

Summary

How does MiniMed Group compare to Penumbra?

Summary

How does MiniMed Group compare to Glaukos?

Summary

How does MiniMed Group compare to Stevanato Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MMED vs. The Competition

MiniMed Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MiniMed Group (MMED) Competitors

MMED vs. SOLV, SNN, PEN, GKOS, and STVN

How does MiniMed Group compare to Solventum?

Is MMED or SOLV more profitable?

Do analysts rate MMED or SOLV?

Does the media prefer MMED or SOLV?

Do insiders and institutionals hold more shares of MMED or SOLV?

Which has higher valuation and earnings, MMED or SOLV?

Summary

How does MiniMed Group compare to Smith & Nephew SNATS?

Does the media prefer MMED or SNN?

Do analysts rate MMED or SNN?

Is MMED or SNN more profitable?

Which has stronger earnings & valuation, MMED or SNN?

Do institutionals & insiders hold more shares of MMED or SNN?

Summary

How does MiniMed Group compare to Penumbra?

Do analysts prefer PEN or MMED?

Does the media prefer PEN or MMED?

Do institutionals and insiders believe in PEN or MMED?

Which has better earnings & valuation, PEN or MMED?

Is PEN or MMED more profitable?

Summary

How does MiniMed Group compare to Glaukos?

Do insiders and institutionals hold more shares of MMED or GKOS?

Which has higher valuation and earnings, MMED or GKOS?

Do analysts recommend MMED or GKOS?

Is MMED or GKOS more profitable?

Does the media refer more to MMED or GKOS?

Summary

How does MiniMed Group compare to Stevanato Group?

Is STVN or MMED more profitable?

Do insiders & institutionals believe in STVN or MMED?

Does the media refer more to STVN or MMED?

Which has stronger earnings and valuation, STVN or MMED?

Do analysts prefer STVN or MMED?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MMED vs. The Competition

MiniMed Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools